Streetbeat News

Stock Prices

MRK

Recent options trading activity for Merck & Co (NYSE:MRK) shows a bearish sentiment among big-money investors, with 50% of trades being bearish. The options trades suggest a price range of $100 to $117 for MRK. The stock is currently trading at $118.45, up by 0.84%, and may be approaching overbought territory. An analyst from Cantor Fitzgerald has lowered its rating to Overweight with a price target of $155.

Portfolio Pulse from Benzinga Insights

August 30, 2024 | 8:33 pm

APTO

Aptose Biosciences shares rose following the announcement of a $10 million loan agreement with Hanmi Pharmaceutical Co.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 8:32 pm

BFI

BurgerFi has received deficiency notices from Nasdaq due to its failure to timely file its Form 10-Q. This could lead to potential delisting if not addressed.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 8:32 pm

NRSN

NeuroSense Therapeutics Ltd. has received a notification from Nasdaq for not meeting the minimum bid price requirement, as its stock has been below $1.00 for 30 consecutive trading days.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 8:31 pm

BDRX

Biodexa Pharmaceuticals has received a listing determination from Nasdaq and plans to appeal the decision.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 8:31 pm

GME

GameStop shares rose by 8.88% to $23.42, driven by upcoming Q2 earnings, a strategic shift in liquidity management, and a retail strategy targeting retro gaming. Despite the stock's rise, retail investor interest remains lower than during the 2021 meme stock frenzy.

Portfolio Pulse from Vaishali Prayag

August 30, 2024 | 8:27 pm

ZBAO

Zhibao Technology shares rise as the company secures a contract to provide high-end medical third party administration services to the People's Insurance Company of China Limited.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 8:26 pm

ALNY

Investors with significant capital have shown interest in Alnylam Pharmaceuticals (NASDAQ:ALNY) options, with a mix of bullish and bearish sentiments. The options activity suggests a price range of $90 to $310. Analysts have varied ratings, with target prices ranging from $198 to $320.

Portfolio Pulse from Benzinga Insights

August 30, 2024 | 8:17 pm

BSX

Boston Scientific (NYSE:BSX) has seen a surge in options activity, with significant transactions indicating a price target between $75.0 and $85.0. Analysts maintain positive ratings, with price targets up to $92. The stock is currently trading at $81.79, up 1.39%, but may be overbought.

Portfolio Pulse from Benzinga Insights

August 30, 2024 | 8:17 pm

STEM

Stem has received a notice from the NYSE for its stock price falling below the $1.00 per share minimum. The company plans to address this deficiency within six months to maintain its listing.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2024 | 8:16 pm